Whey Protein Market Size, Growth, Demands Outlook and Forecasts to 2032

According to the research report, the global wheyprotein market size is expected to touch USD 21.36 Billion by 2032, from USD 12.41 Billion in 2022, growing with a significant CAGR of 5.58% from 2022 to 2032. 

The whey protein report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global whey protein in conjunction with the geographical landscape of this vertical have also been included in this report.

The report offers intricate dynamics about different aspects of the global whey protein market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global whey protein during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).

Sample Link @ https://www.precedenceresearch.com/sample/2530

 Report Scope of the Whey Protein Market

Report Coverage	Details
Market Size in 2023	USD 13.1 Billion
Market Size by 2032	USD 21.36 Billion
Growth Rate from 2023 to 2032	CAGR of 5.58%
Largest Market	North America
Base Year	2022
Forecast Period	2023 to 2032
Segments Covered	By Type, By Application, By Distribution Channel and By End Users

This study covers a detailed segmentation of the global whey protein market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global whey protein market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.

Key Players

• Glanbia plc. (Ireland)
• Now Health Group, Inc. (U.S.)
• Nutiva Inc (U.S.)
• The Simply Good Food Co (U.S.)
• Iovate Health Sciences International Inc. (Canada)
• MusclePharm Corporation (U.S.)
• Kerry Group Plc (Ireland)
• CytoSport, Inc. (U.S.)
• The Nature's Bounty Co. (U.S.)
• Reliance Vitamin Company, Inc. (U.S.)
• Herbalife Nutrition, Inc. (U.S.)
• Danone SA (France)
• General Nutrition Centers (GNC) Holdings, Inc. (U.S.)
• Orgain Inc. (U.S.)
• True Nutrition (U.S.)

Market Segmentation

 By Type

• Isolates
• Concentrates
• Demineralized
• Hydrolysate

By Application

• Nutritional
• Personal Care
• Food
• Feed
• Infant Formula
• Sports and Performance Nutrition
• Functional/Fortified Food

By Distribution channel

• Supermarkets/Hypermarkets
• Convenience Stores
• Specialty Stores
• Online Stores
• Other Distribution Channels

By End Users

• Athletes
• Bodybuilders
• Lifestyle Users

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• The Middle East and Africa

Research Methodology

The research methodology adopted by analysts for compiling the global whey protein report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.

During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.

For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global whey protein market.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Whey Protein Market 

5.1. COVID-19 Landscape: Whey Protein Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Whey Protein Market, By Type

8.1. Whey Protein Market, by Type, 2023-2032

8.1.1. Isolates

8.1.1.1. Market Revenue and Forecast (2023-2032)

8.1.2. Concentrates

8.1.2.1. Market Revenue and Forecast (2023-2032)

8.1.3. Demineralized

8.1.3.1. Market Revenue and Forecast (2023-2032)

8.1.4. Hydrolysate

8.1.4.1. Market Revenue and Forecast (2023-2032)

Chapter 9. Global Whey Protein Market, By Application

9.1. Whey Protein Market, by Application, 2023-2032

9.1.1. Nutritional

9.1.1.1. Market Revenue and Forecast (2023-2032)

9.1.2. Personal Care

9.1.2.1. Market Revenue and Forecast (2023-2032)

9.1.3. Food

9.1.3.1. Market Revenue and Forecast (2023-2032)

9.1.4. Feed

9.1.4.1. Market Revenue and Forecast (2023-2032)

9.1.5. Infant Formula

9.1.5.1. Market Revenue and Forecast (2023-2032)

9.1.6. Sports and Performance Nutrition

9.1.6.1. Market Revenue and Forecast (2023-2032)

9.1.7. Functional/Fortified Food

9.1.7.1. Market Revenue and Forecast (2023-2032)

Chapter 10. Global Whey Protein Market, By Distribution channel 

10.1. Whey Protein Market, by Distribution channel, 2023-2032

10.1.1. Supermarkets/Hypermarkets

10.1.1.1. Market Revenue and Forecast (2023-2032)

10.1.2. Convenience Stores

10.1.2.1. Market Revenue and Forecast (2023-2032)

10.1.3. Specialty Stores

10.1.3.1. Market Revenue and Forecast (2023-2032)

10.1.4. Online Stores

10.1.4.1. Market Revenue and Forecast (2023-2032)

10.1.5. Other Distribution Channels

10.1.5.1. Market Revenue and Forecast (2023-2032)

Chapter 11. Global Whey Protein Market, By End Users 

11.1. Whey Protein Market, by End Users, 2023-2032

11.1.1. Athletes

11.1.1.1. Market Revenue and Forecast (2023-2032)

11.1.2. Bodybuilders

11.1.2.1. Market Revenue and Forecast (2023-2032)

11.1.3. Lifestyle Users

11.1.3.1. Market Revenue and Forecast (2023-2032)

Chapter 12. Global Whey Protein Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Type (2023-2032)

12.1.2. Market Revenue and Forecast, by Application (2023-2032)

12.1.3. Market Revenue and Forecast, by Distribution channel (2023-2032)

12.1.4. Market Revenue and Forecast, by End Users (2023-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Type (2023-2032)

12.1.5.2. Market Revenue and Forecast, by Application (2023-2032)

12.1.5.3. Market Revenue and Forecast, by Distribution channel (2023-2032)

12.1.5.4. Market Revenue and Forecast, by End Users (2023-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Type (2023-2032)

12.1.6.2. Market Revenue and Forecast, by Application (2023-2032)

12.1.6.3. Market Revenue and Forecast, by Distribution channel (2023-2032)

12.1.6.4. Market Revenue and Forecast, by End Users (2023-2032)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Type (2023-2032)

12.2.2. Market Revenue and Forecast, by Application (2023-2032)

12.2.3. Market Revenue and Forecast, by Distribution channel (2023-2032)

12.2.4. Market Revenue and Forecast, by End Users (2023-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Type (2023-2032)

12.2.5.2. Market Revenue and Forecast, by Application (2023-2032)

12.2.5.3. Market Revenue and Forecast, by Distribution channel (2023-2032)

12.2.5.4. Market Revenue and Forecast, by End Users (2023-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Type (2023-2032)

12.2.6.2. Market Revenue and Forecast, by Application (2023-2032)

12.2.6.3. Market Revenue and Forecast, by Distribution channel (2023-2032)

12.2.6.4. Market Revenue and Forecast, by End Users (2023-2032)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Type (2023-2032)

12.2.7.2. Market Revenue and Forecast, by Application (2023-2032)

12.2.7.3. Market Revenue and Forecast, by Distribution channel (2023-2032)

12.2.7.4. Market Revenue and Forecast, by End Users (2023-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Type (2023-2032)

12.2.8.2. Market Revenue and Forecast, by Application (2023-2032)

12.2.8.3. Market Revenue and Forecast, by Distribution channel (2023-2032)

12.2.8.4. Market Revenue and Forecast, by End Users (2023-2032)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Type (2023-2032)

12.3.2. Market Revenue and Forecast, by Application (2023-2032)

12.3.3. Market Revenue and Forecast, by Distribution channel (2023-2032)

12.3.4. Market Revenue and Forecast, by End Users (2023-2032)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Type (2023-2032)

12.3.5.2. Market Revenue and Forecast, by Application (2023-2032)

12.3.5.3. Market Revenue and Forecast, by Distribution channel (2023-2032)

12.3.5.4. Market Revenue and Forecast, by End Users (2023-2032)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Type (2023-2032)

12.3.6.2. Market Revenue and Forecast, by Application (2023-2032)

12.3.6.3. Market Revenue and Forecast, by Distribution channel (2023-2032)

12.3.6.4. Market Revenue and Forecast, by End Users (2023-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Type (2023-2032)

12.3.7.2. Market Revenue and Forecast, by Application (2023-2032)

12.3.7.3. Market Revenue and Forecast, by Distribution channel (2023-2032)

12.3.7.4. Market Revenue and Forecast, by End Users (2023-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Type (2023-2032)

12.3.8.2. Market Revenue and Forecast, by Application (2023-2032)

12.3.8.3. Market Revenue and Forecast, by Distribution channel (2023-2032)

12.3.8.4. Market Revenue and Forecast, by End Users (2023-2032)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Type (2023-2032)

12.4.2. Market Revenue and Forecast, by Application (2023-2032)

12.4.3. Market Revenue and Forecast, by Distribution channel (2023-2032)

12.4.4. Market Revenue and Forecast, by End Users (2023-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Type (2023-2032)

12.4.5.2. Market Revenue and Forecast, by Application (2023-2032)

12.4.5.3. Market Revenue and Forecast, by Distribution channel (2023-2032)

12.4.5.4. Market Revenue and Forecast, by End Users (2023-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Type (2023-2032)

12.4.6.2. Market Revenue and Forecast, by Application (2023-2032)

12.4.6.3. Market Revenue and Forecast, by Distribution channel (2023-2032)

12.4.6.4. Market Revenue and Forecast, by End Users (2023-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Type (2023-2032)

12.4.7.2. Market Revenue and Forecast, by Application (2023-2032)

12.4.7.3. Market Revenue and Forecast, by Distribution channel (2023-2032)

12.4.7.4. Market Revenue and Forecast, by End Users (2023-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Type (2023-2032)

12.4.8.2. Market Revenue and Forecast, by Application (2023-2032)

12.4.8.3. Market Revenue and Forecast, by Distribution channel (2023-2032)

12.4.8.4. Market Revenue and Forecast, by End Users (2023-2032)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Type (2023-2032)

12.5.2. Market Revenue and Forecast, by Application (2023-2032)

12.5.3. Market Revenue and Forecast, by Distribution channel (2023-2032)

12.5.4. Market Revenue and Forecast, by End Users (2023-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Type (2023-2032)

12.5.5.2. Market Revenue and Forecast, by Application (2023-2032)

12.5.5.3. Market Revenue and Forecast, by Distribution channel (2023-2032)

12.5.5.4. Market Revenue and Forecast, by End Users (2023-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Type (2023-2032)

12.5.6.2. Market Revenue and Forecast, by Application (2023-2032)

12.5.6.3. Market Revenue and Forecast, by Distribution channel (2023-2032)

12.5.6.4. Market Revenue and Forecast, by End Users (2023-2032)

Chapter 13. Company Profiles

13.1. Glanbia plc. (Ireland)

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Now Health Group, Inc. (U.S.)

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Nutiva Inc (U.S.)

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. The Simply Good Food Co (U.S.)

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Iovate Health Sciences International Inc. (Canada)

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. MusclePharm Corporation (U.S.)

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Kerry Group Plc (Ireland)

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. CytoSport, Inc. (U.S.)

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. The Nature's Bounty Co. (U.S.)

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Reliance Vitamin Company, Inc. (U.S.)

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com